Skip to main content
. 2021 Oct 21;18(10):e1003807. doi: 10.1371/journal.pmed.1003807

Table 3. SARS-CoV-2–related mortality presented by month in a cohort of 9.1 million VA enrollees followed from February 2020 to February 2021.

Number of SARS-CoV-2–related deaths per month (and mortality per 100,000 persons per month)
Time period and number of VA enrollees at risk* Entire period: February 2020 to February 2021
N = 9,127,673
February to March 2020
N = 9,127,673
April 2020
N = 9,090,196
May 2020
N = 9,053,082
June 2020
N = 9,022,051
July 2020
N = 8,990,833
August 2020
N = 8,948,674
September 2020
N = 8,913,864
October 2020
N = 8,881,573
November 2020
N = 8,844,680
December 2020
N = 8,804,424
January 2021
N = 8,744,388
February 2021
N = 8,671,916
All persons 10,230
(9.3)
83
(0.9)
775
(8.5)
631
(7.0)
295
(3.3)
627
(7.0)
604
(6.7)
375
(4.2)
500
(5.6)
1,165
(13.2)
2,019
(22.8)
2,172
(24.7)
984
(11.3)
Sex
Female 208
(2.1)
1
(0.1)
14
(1.7)
18
(2.2)
7
(0.8)
14
(1.7)
15
(1.8)
3
(0.4)
11
(1.3)
21
(2.6)
42
(5.1)
38
(4.7)
24
(3.0)
Male 10,022
(10.1)
82
(1.0)
761
(9.2)
613
(7.4)
288
(3.5)
613
(7.5)
589
(7.2)
372
(4.6)
489
(6.1)
1,144
(14.2)
1,977
(24.7)
2,134
(26.8)
960
(12.1)
Age (years)
18 to 24 0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
25 to 34 10
(0.1)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
2
(0.2)
3
(0.4)
5
(0.6)
35 to 44 40
(0.3)
0
(0.0)
1
(0.1)
3
(0.3)
0
(0.0)
5
(0.5)
0
(0.0)
1
(0.1)
1
(0.1)
1
(0.1)
7
(0.7)
13
(1.2)
8
(0.8)
45 to 54 153
(1.1)
4
(0.3)
16
(1.4)
8
(0.7)
4
(0.3)
10
(0.9)
12
(1.0)
7
(0.6)
10
(0.9)
9
(0.8)
34
(2.9)
28
(2.4)
11
(1.0)
55 to 64 743
(4.1)
11
(0.7)
71
(4.7)
36
(2.4)
26
(1.7)
59
(3.9)
54
(3.6)
21
(1.4)
30
(2.0)
68
(4.6)
134
(9.0)
160
(10.8)
73
(5.0)
65 to 74 3,354
(11.5)
28
(1.1)
272
(11.2)
181
(7.5)
86
(3.6)
213
(8.9)
206
(8.6)
125
(5.2)
165
(6.9)
363
(15.3)
662
(28.0)
733
(31.2)
320
(13.8)
75 to 84 2,993
(19.8)
20
(1.6)
180
(14.4)
157
(12.7)
77
(6.2)
171
(14.0)
162
(13.3)
113
(9.3)
148
(12.3)
366
(30.7)
629
(52.8)
656
(55.5)
314
(26.9)
≥85 2,937
(32.0)
20
(2.6)
235
(31.3)
246
(33.4)
102
(14.0)
169
(23.6)
170
(24.1)
108
(15.5)
146
(21.3)
358
(52.9)
551
(81.9)
579
(86.9)
253
(38.9)
Race
White 7,273
(10.3)
34
(0.6)
411
(7.0)
406
(7.0)
194
(3.3)
409
(7.1)
396
(6.9)
271
(4.7)
398
(7.0)
913
(16.0)
1,541
(27.1)
1,561
(27.6)
739
(13.2)
Black 1,935
(12.1)
44
(3.3)
309
(23.2)
174
(13.1)
74
(5.6)
150
(11.4)
138
(10.5)
62
(4.7)
59
(4.5)
112
(8.6)
277
(21.4)
374
(29.0)
162
(12.7)
Asian 65
(4.7)
0
(0.0)
3
(2.6)
6
(5.2)
2
(1.8)
3
(2.6)
8
(7.0)
5
(4.4)
1
(0.9)
2
(1.8)
15
(13.3)
15
(13.3)
5
(4.5)
AI/AN 125
(13.1)
0
(0.0)
6
(7.5)
5
(6.3)
4
(5.1)
9
(11.4)
8
(10.2)
7
(9.0)
9
(11.6)
14
(18.0)
27
(34.9)
28
(36.4)
8
(10.5)
PI/NH 87
(9.6)
1
(1.3)
4
(5.3)
3
(4.0)
3
(4.0)
6
(8.1)
4
(5.4)
2
(2.7)
3
(4.1)
12
(16.4)
20
(27.3)
21
(28.9)
8
(11.1)
Missing/unknown/refused 745
(3.8)
4
(0.2)
42
(2.6)
37
(2.3)
18
(1.1)
50
(3.1)
50
(3.1)
28
(1.7)
30
(1.9)
112
(7.0)
139
(8.7)
173
(10.9)
62
(3.9)
Ethnicity
Non-Hispanic 9,097
(10.5)
75
(1.0)
711
(9.9)
577
(8.1)
257
(3.6)
516
(7.3)
529
(7.5)
341
(4.8)
458
(6.5)
1,053
(15.1)
1,813
(26.1)
1,904
(27.5)
863
(12.6)
Hispanic 745
(10.9)
8
(1.4)
45
(7.9)
32
(5.6)
28
(4.9)
89
(15.7)
51
(9.0)
21
(3.7)
23
(4.1)
75
(13.5)
133
(23.9)
158
(28.6)
82
(15.0)
Missing/unknown/refused 388
(2.4)
0
(0.0)
19
(1.4)
22
(1.6)
10
(0.7)
22
(1.6)
24
(1.8)
13
(1.0)
19
(1.4)
37
(2.8)
73
(5.5)
110
(8.3)
39
(3.0)
US Federal Region
1 418
(8.7)
2
(0.5)
99
(24.8)
86
(21.7)
13
(3.3)
6
(1.5)
6
(1.5)
3
(0.8)
3
(0.8)
24
(6.2)
70
(18.1)
65
(16.9)
41
(10.7)
2 704
(8.8)
24
(3.6)
237
(35.8)
115
(17.5)
16
(2.5)
13
(2.0)
4
(0.6)
5
(0.8)
9
(1.4)
25
(3.9)
82
(12.8)
114
(17.9)
60
(9.5)
3 905
(7.9)
3
(0.3)
86
(9.0)
72
(7.6)
36
(3.8)
29
(3.1)
31
(3.3)
19
(2.0)
46
(4.9)
80
(8.6)
190
(20.4)
213
(23.0)
100
(10.9)
4 2,385
(8.7)
7
(0.3)
77
(3.4)
106
(4.7)
85
(3.7)
209
(9.2)
237
(10.5)
145
(6.5)
116
(5.2)
181
(8.1)
362
(16.3)
590
(26.7)
270
(12.3)
5 1,567
(9.8)
17
(1.3)
134
(10.2)
113
(8.6)
41
(3.1)
34
(2.6)
56
(4.3)
35
(2.7)
78
(6.0)
316
(24.6)
387
(30.2)
236
(18.6)
120
(9.5)
6 1,567
(10.9)
20
(1.7)
74
(6.2)
48
(4.0)
33
(2.8)
179
(15.2)
133
(11.3)
53
(4.5)
91
(7.8)
212
(18.3)
273
(23.6)
306
(26.6)
145
(12.7)
7 710
(12.9)
2
(0.4)
16
(3.5)
28
(6.2)
9
(2.0)
12
(2.7)
35
(7.8)
53
(11.8)
67
(15.0)
143
(32.2)
170
(38.5)
125
(28.6)
50
(11.6)
8 387
(8.6)
2
(0.5)
11
(2.9)
24
(6.5)
11
(3.0)
8
(2.2)
7
(1.9)
19
(5.2)
48
(13.1)
83
(22.7)
104
(28.6)
51
(14.1)
19
(5.3)
9 1,340
(10.7)
3
(0.3)
33
(3.2)
26
(2.5)
46
(4.5)
123
(12.0)
76
(7.4)
30
(2.9)
28
(2.8)
68
(6.7)
325
(32.1)
425
(42.2)
157
(15.8)
10 247
(4.9)
3
(0.7)
8
(1.9)
13
(3.1)
5
(1.2)
14
(3.4)
19
(4.6)
13
(3.2)
14
(3.4)
33
(8.1)
56
(13.7)
47
(11.6)
22
(5.4)
Urban versus rural
Rural 5,002
(9.3)
20
(0.4)
151
(3.4)
171
(3.9)
116
(2.6)
263
(6.0)
319
(7.3)
226
(5.2)
320
(7.3)
707
(16.3)
1,124
(26.0)
1,104
(25.6)
481
(11.3)
Urban 5,228
(9.4)
63
(1.4)
624
(13.4)
460
(10.0)
179
(3.9)
364
(7.9)
285
(6.2)
149
(3.3)
180
(4.0)
458
(10.1)
895
(19.9)
1,068
(23.8)
503
(11.3)
BMI (kg/m2)
<18.5 (underweight) 304
(39.2)
3
(4.6)
28
(44.4)
28
(45.2)
16
(26.3)
19
(31.8)
15
(25.5)
10
(17.3)
12
(21.0)
32
(56.7)
46
(82.0)
66
(118.8)
29
(53.2)
18.5 to <25 (normal weight) 2,660
(12.0)
21
(1.1)
222
(12.1)
215
(11.8)
83
(4.6)
158
(8.8)
158
(8.8)
108
(6.1)
108
(6.1)
261
(14.8)
503
(28.6)
549
(31.4)
274
(15.8)
25 to <30 (overweight) 3,244
(8.2)
29
(0.9)
254
(7.7)
188
(5.7)
82
(2.5)
201
(6.1)
175
(5.4)
125
(3.9)
160
(4.9)
368
(11.4)
636
(19.8)
718
(22.4)
308
(9.7)
30 to <35 (obese I) 2,262
(7.7)
13
(0.5)
140
(5.8)
127
(5.2)
64
(2.7)
146
(6.1)
125
(5.2)
81
(3.4)
117
(4.9)
291
(12.2)
466
(19.6)
481
(20.4)
211
(9.0)
35 to <40 (obese II) 1,091
(8.9)
12
(1.2)
78
(7.6)
41
(4.0)
30
(2.9)
57
(5.6)
92
(9.1)
33
(3.3)
54
(5.4)
120
(12.0)
236
(23.6)
235
(23.6)
103
(10.5)
≥40 (obese III) 669
(12.5)
5
(1.1)
53
(11.9)
32
(7.2)
20
(4.5)
46
(10.4)
39
(8.9)
18
(4.1)
49
(11.2)
93
(21.4)
132
(30.5)
123
(28.6)
59
(13.9)
CCI
0 to 1 1,450
(2.0)
9
(0.1)
94
(1.6)
98
(1.6)
43
(0.7)
88
(1.5)
93
(1.5)
61
(1.0)
73
(1.2)
176
(3.0)
279
(4.7)
308
(5.2)
128
(2.2)
2 to 3 2,156
(11.8)
20
(1.3)
157
(10.4)
115
(7.6)
50
(3.3)
122
(8.2)
127
(8.5)
78
(5.3)
125
(8.5)
244
(16.7)
470
(32.2)
429
(29.6)
219
(15.3)
4 to 5 2,331
(25.3)
11
(1.4)
161
(21.1)
131
(17.3)
75
(10.0)
138
(18.4)
137
(18.4)
88
(11.9)
89
(12.1)
284
(39.0)
467
(64.3)
512
(71.2)
238
(33.6)
≥6 4,293
(46.2)
43
(5.6)
363
(47.5)
287
(38.0)
127
(17.0)
279
(37.7)
247
(33.8)
148
(20.5)
213
(29.9)
461
(65.3)
803
(114.5)
923
(133.3)
399
(58.9)

* VA enrollees at risk are those who are still alive at the beginning of each time period and had not been infected with SARS-CoV-2 more than 30 days before the beginning of the time period.

Categorized according to the 10 Federal Regions drawn up by the Federal Emergency Management Agency: 1 (CT, MA, ME, NH, RI, and VT), 2 (NJ, NY, and PR), 3 (DC, DE, MD, PA, VA, and WV), 4 (AL, FL, GA, KY, MS, NC, SC, and TN), 5 (IL, IN, MI, MN, OH, and WI), 6 (AR, LA, NM, OK, and TX), 7 (IA, KS, MO, and NE), 8 (CO, MT, ND, SD, UT, and WY), 9 (AZ, CA, GU, HI, and NV), and 10 (AK, ID, OR, and WA).

AI/AN, American Indian/Alaska Native; CCI, Charlson comorbidity index; PI/NH, Pacific Islander/Native Hawaiian; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; VA, Veterans Affairs.